Friday, March 31, 2023

New #Stocks and #TradingIdeas; (TSX: $TAL.TO) (TSXV: $SOU.V) (Nasdaq: $SYBX) (LSE:ROQ) (Nasdaq: $CLVR)

  New #Stocks and #TradingIdeas; (TSX: $TAL.TO) (TSXV: $SOU.V) (Nasdaq: $SYBX) (LSE:ROQ) (Nasdaq: $CLVR)

 

Stocks to watch in #Energy, #Biotech and #Cannabis

 

 



 

 

Vancouver, Kelowna, Delta, March 31, 2023 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Energy, Biotech and Cannabis. Today’s stocks have been added to our lists of free stock directories in each sector.

 

Read this in full at https://www.investorideas.com/news/2023/main/03311Stocks.asp

 

The newest energy companies are involved in oil & gas and natural gas development and exploration.

 

The latest biotech companies are involved in treatments for gout and the oncology market.

 

The newest cannabis company operates in Colombia.

 

New Stocks Added to Energy Directories:

PetroTal Corp. (TSX:TAL) is a publicly traded oil and gas development and production Company domiciled in Calgary, Alberta, focused on the development of oil assets in Peru. PetroTal's flagship asset is its 100% working interest in Bretana oil field in Peru's Block 95 where oil production was initiated in June 2018. In early 2022, PetroTal became the largest crude oil producer in Peru. The Company's management team has significant experience in developing and exploring for oil in Peru and is led by a Board of Directors that is focused on safely and cost effectively developing the Bretana oil field. It is actively building new initiatives to champion community sensitive energy production, benefiting all stakeholders

 

Southern Energy Corp. (OTCQX: SOUTF;  TSXV: SOU) is a natural gas exploration and production company. Southern has a primary focus on acquiring and developing conventional natural gas and light oil resources in the southeast Gulf States of Mississippi, Louisiana, and East Texas. Our management team has a long and successful history working together and have created significant shareholder value through accretive acquisitions, optimization of existing oil and natural gas fields and the utilization of re-development strategies utilizing horizontal drilling and multi-staged fracture completion techniques.

New Stocks Added to Biotech Directories:

Synlogic, Inc. (Nasdaq: SYBX) is the leading company advancing therapeutics based on synthetic biology. Synlogic’s pipeline includes its lead program in phenylketonuria (PKU), which has demonstrated proof of concept with plans to start a pivotal, Phase 3 study in the first half of 2023, and additional novel drug candidates designed to treat homocystinuria (HCU), enteric hyperoxaluria and gout. The rapid advancement of these potential biotherapeutics, called Synthetic Biotics, has been enabled by Synlogic’s reproducible, target-specific drug design. Synlogic uses programmable, precision genetic engineering of well-characterized probiotics to exert localized activity for therapeutic benefit, with a focus on metabolic and immunological diseases. In addition to its clinical programs, Synlogic has a research collaboration with Roche on the discovery of a novel Synthetic Biotic for the treatment of inflammatory bowel disease or IBD. Synlogic has also developed two drug candidates through a research collaboration with Ginkgo Bioworks: SYNB1353, designed to consume methionine for the potential treatment of HCU, and SYNB2081, designed to lower uric acid for the potential treatment of gout.

 

Roquefort Therapeutics plc (LSE: ROQ) is a material biotech company focused on developing first in class, next generation medicines in the high value and high growth oncology market prior to partnering or selling to big pharma. The Company has partnered with leading academic cancer research centres which complements our own world-class in-house expertise and laboratory infrastructure.

New Stocks Added to Cannabis Directories:

Clever Leaves Holdings Inc. (Nasdaq: CLVR) is a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids. Its operations in Colombia produce cannabinoid active pharmaceutical ingredients (API) and finished products in flower and extract form to a growing base of B2B customers around the globe. Clever Leaves aims to disrupt the traditional cannabis production industry by leveraging environmentally sustainable, ESG-friendly, industrial-scale and low-cost production methods, with the world’s most stringent pharmaceutical quality certifications.

 

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

About Investorideas.com - Big Investing Ideas

We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders.  Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast ,  Cleantech and Climate Change Podcast,  Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast.  We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water. 

 

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com

800 665 0411

 


Wednesday, March 29, 2023

Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis, CBD and Psychedelics Industry March 20th, 2023 - March 24th, 2023

Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis, CBD and Psychedelics Industry March 20th, 2023 - March 24th, 2023

 

March 29, 2023 (Investorideas.com Newswire) KEY INSIGHTS & TAKEAWAYS


https://www.investorideas.com/news/2023/cannabis/03291DealTracker.asp 

Friday, March 24, 2023

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move: (OTCQX: $GRAMF), Holy Roller, #Legalisation Efforts in the #US and #Europe and #CannabisSeizures

 



 

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move: (OTCQX: $GRAMF), Holy Roller, #Legalisation Efforts in the #US and #Europe and #CannabisSeizures

 

Delta, Kelowna, BC, March 24, 2023 (Investorideas.com Newswire), investorideas.com,  a global news source covering leading sectors including marijuana and hemp stocks and its potcast site  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2023/032423-Cannabis.mp3

 

Read this in full at https://www.investorideas.com/news/2023/cannabis-potcasts/03241Legalization-Efforts-US-Europe.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

In today’s podcast we go over a few industry announcements, legalisation efforts in the US and Europe and the continuation of cannabis seizures.

 

TPCO Holding Corp. (The Parent Company) (NEO: GRAM.U) (OTCQX: GRAMF), a leading consumer-focused California cannabis company, announced the exclusive launch of Cruisers, a new all-FUN, no-frills brand that puts consumers first and offers everyday value on premium cannabis products. Cruisers combines the Company's existing brands, Fun Uncle and DELI, streamlining these top-performing products into a single consumer-centric destination.  By skipping the doldrums of the daily grind, Cruisers transports consumers to that carefree place where the bowl is always full. The weed wizards at Cruisers combine high-quality with tasty custom flavours for good times only. Cruisers launched statewide in California on Wednesday, March 22nd, with prime availability in all The Parent Company-owned retail locations.

 

Providing high-quality distraction from the ordinary, Cruisers offers budget pricing for various cannabis products in all key categories, including best-selling distillate and live resin vapes, whole flower, gummies, and preroll products, including the debut of Cruisers' new infused prerolls. Infused prerolls, one of the fastest growing categories according to Headset, will be available in the 1g single and the extremely popular 5-pk mini formats. Cruisers' new vape products utilise the same unique formulas and flavours that made Fun Uncle the #1 selling value ($20-$30) vape in California, according to BDSA data. Additional products offered at the brand's launch include the new Cruisers' 1g Infused single pre-rolls featuring high-THC distillate and a kief coating in flavours like Blueberry Cookies, Strawberry Gelato, and Maui Wowie.

 

"I am thrilled to announce the launch of Cruisers. Combining Fun Uncle and DELI, which are two of our most beloved and disruptive brands, Cruisers will continue to feature  high-quality products at a competitive, value price point. In our retail locations, Cruisers will be the best priced offering in every category it plays in," said Troy Datcher, CEO & Chairman of the Board at The Parent Company. "The new brand name was inspired by Fun Uncle "Cruisers" Vapes, which quickly became the #1 selling vape in the value segment. As we continue to prioritise building our portfolio of top-tier brands, we are committed to serving our customers' most essential needs through innovative and consistent brands."

 

To celebrate the launch of Cruisers, the Company will host "All Fun Fridays" in-store activations at Caliva San Jose, Varda Pasadena, Calma WeHo, and Coastal Santa Barbara starting today, Friday, March 24th. All Fun Fridays run every Friday from March 24th through April 14th and will feature branded swag giveaways and in-store promotions.

 

GreenBroz Inc., the leader in post-harvest processing technology, has announced the Holy Roller, an evolutionary leap in high-capacity pre-roll machines. It can produce 3000+ cones per hour with unrivalled fill accuracy and consistency.



 

The Holy Roller is the product of extensive R&D by an engineering team with over three decades of experience in cannabis and automated packaging. The machine achieves an impressive output rate with unmatched consistency and only a .0012 density variance. This is over 10x more precise than any other pre-roll machine on the market.

 

"When we decided to pursue automation of making the perfect joint, we knew we needed something designed with the real-world properties of cannabis in mind," said Cullen Raichart, GreenBroz CEO.

 

"We focused on consistency, which is the lifeblood of your brand, and on what consumers desire: pre-rolls packed densely and evenly and filled with a coarse grind for proper airflow. We are proud to release a machine that delivers all of those qualities, producing cones that are not only identical but provide the same great user experience every time."

 

To achieve superior accuracy and efficiency, the Holy Roller uses active weighing technology and proprietary cannabis separation technology, eliminating discrepancies in cone fills and cutting down on clogs. Pre-roll producers will be able to make joints ranging from .35 grams to a full gram with one universal cone, which allows them to fulfil multiple product SKUs and streamline ordering, storage, and inventory.

 

The Holy Roller is the only commercial cone-filling machine on the market engineered to accommodate whatever grind size the operator chooses to use, including the 3mm grind, the optimal particle size for smokability and flavour.

 

"Getting a better understanding of what's happening inside pre-rolls when consumers smoke them is vital to improving quality. After extensive airflow testing, we have found that the 3mm grind allows the air to travel through the length of the cone more efficiently and burn evenly, giving consumers a smoother smoking experience," said Raichart.

 

"The Holy Roller is a real game-changer and gives pre-roll producers an edge in the highly competitive market, providing them with the perfect mix of quality, quantity, uniformity, and airflow to position their brand as a leader in consistency."

 

To accommodate different operational needs, the machine is available in 2 or 4-lane variants.

 

recent article from Marijuna Moment, discussed how The Wine & Spirits Wholesalers of America (WSWA) has officially endorsed the legalisation of marijuana at the federal level and has released a policy paper that outlines regulatory priorities to support this effort.

 

The association suggested that regulations for marijuana should follow the model of alcohol regulations to promote industry competition, innovation, and public safety. WSWA acknowledged that federal regulations should not replace state-established regulations entirely, but some level of federal oversight and taxation could help support state programs and promote normalisation of the cannabis industry.

 

“Americans have confidence in our regulated alcohol system and our experience can benefit lawmakers creating a U.S. adult-use cannabis market,” WSWA CEO Michelle Korsmo said in a press release on Friday. “WSWA members have successfully partnered with suppliers and distributed socially sensitive products to locally licensed retailers for the last century.”

 

“The U.S. alcohol marketplace is the safest and most diverse in the world because of the smart and enforceable federal regulatory model that ensures product integrity, efficient tax collection and public safety,” Korsmo said.

 

WSWA detailed four key principles for federal oversight of an adult-use marijuana supply chain:

1. The federal permitting of cannabis producers, importers, testing facilities and distributors.

The association said states should manage licensing for marijuana retailers, but it recommended that the federal government require permits for cannabis producers, importers, testing facilities and distributors through the Department of Treasury’s Alcohol and Tobacco Tax and Trade Bureau (TTB).

 

2. The approval and regulation of cannabis products.

New cannabis products should be subject to pre-market approval and federal registration, also through TTB, the association said. That would support existing quality control policies that are in place at the state level.

A standardised label should be included on all marijuana items, too. They should feature information, at a minimum, about the product name, THC potency, net content, producer name and address, a government health warning and the country of origin (for imports).

 

3. The efficient and effective collection of federal excise tax.

WSWA advised that a federal excise tax should be imposed for cannabis products at the producer or importer level, and it should be based on potency just as beverages are taxed based on alcohol concentration. The taxes should be payable to TTB on a semimonthly basis.

 

4. Effective measures to ensure public safety.

With respect to public safety, the association focused on deterring impaired driving, and it said that lawmakers should prioritize collaborative partnerships with law enforcement and researchers to develop technology that can identify active impairment from cannabis while also funding training for drug recognition experts on the roads.

 

WSWA, which came out in support of states rights to legalize cannabis in 2018, ended its policy brief by explaining why it’s taking this step to advise on federal reform. Since the end of alcohol prohibition, a “safe and economically vibrant marketplace has developed—one that serves the dual needs of regulators and consumers,” it said.

 

“While individual regulations have been modified over time, the basic federal regulatory structure of permitting and tax collection has stood the test of time,” WSWA’s paper, which was noted earlier by Politico, says. “As policymakers consider the future of adult-use cannabis, we believe it is important to share the learnings of our industry. America’s wine and spirits wholesalers are a proud part of this system and believe that the principles outlined here can be extended to a national adult-use cannabis system.”

 

In news from Europe we see a renewed push for legalisation efforts as Germany  is expected to introduce a bill to legalize marijuana in the coming weeks. Marijuana is largely decriminalised in Germany, but the bill would declassify cannabis as a narcotic, allowing citizens over age 18 to carry up to 30 grams, or just over one ounce, for personal use. Residents would also be allowed to legally grow up to three marijuana plants in their homes and cannabis products could be sold in licensed stores.

 

Meanwhile in Zurich, both the city and the University of Zurich will launch a study titled “Züri Can—Cannabis with Responsibility” that will examine the possibilities and effects of the regulated sale and consumption of the drug among a test group of 2,100 residents.

 

Switzerland has allowed the sale of medical cannabis with less than 1% THC since 2011. The country decriminalized recreational cannabis possession in 2013, but even consumers caught with less than 10 grams (.35 ounces) can still be fined.

 

The authors of the Zurich study hope to provide real-world evidence to support policy making efforts. The results could help draft regulations based on levels of cannabis usage that promote individual and public health and safety. Similar studies with universities are planned to roll out in the coming months. Those studies will run across Switzerland including in Basel, Bern, Lausanne, Geneva, Biel, Thun, Olten, and Winterthur.

 

France is also undergoing a trial program expected to be complete by March 2024, providing free medical marijuana treatment to 3,000 patients. The country currently only allows cannabis-derived medicines for medical purposes and has a strict approach to recreational use. The country’s policies have mellowed, though. In 2018, France passed new regulations that reduced the penalty for possession of marijuana to a fine of approximately 200 euros.

 

Lastly, we look at cannabis related seizures, and why this continues.

 

In recent news, last week on March 18, 2023, as a result of the vigilance of staff members, a package containing contraband and unauthorised items was seized on the perimeter of the Federal Training Centre, a multi-level security federal institution.

 

The contraband and unauthorised items seized included 177 grams of marijuana, 119 grams of hashish, 5 grams of cocaine, 4 grams of cannabis wax, and 441 grams of tobacco. The total estimated institutional value of the items seized is $47,124.

 

The Correctional Service of Canada (CSC) uses a number of tools to prevent drugs from entering its institutions. These tools include ion scanners and drug-detector dogs to search buildings, personal property, inmates, and visitors.

 

CSC is heightening measures to prevent contraband from entering its institutions in order to help ensure a safe and secure environment for everyone. CSC also works in partnership with the police to take action against those who attempt to introduce contraband into correctional institutions.

 

CSC has also set up a telephone tip line for all federal institutions so that it may receive additional information about activities relating to security at CSC institutions. These activities may be related to drug use or trafficking that may threaten the safety and security of visitors, inmates, and staff members working at CSC institutions.

 

The toll-free number, 1–866–780–3784, helps ensure that the information shared is protected and that callers remain anonymous.

 

In B.C. news, The Community Safety Unit from the Ministry of Public Safety and Solicitor General in British Columbia, Canada, recently confiscated virtually the entire stock of the Victoria Cannabis Buyers Club.

 

The Club's founder, Ted Smith, stated that between $80,000 and $100,000 worth of products were taken. The Club serves about 3,000 people per month, many of whom rely on its products for a range of medical conditions.

 

“People count on our medicines for a range of conditions from cancer to chronic pain to epilepsy, arthritis, diabetes.”

 

The Community Safety Unit is responsible for enforcing the Cannabis Control and Licensing Act and focuses on the illegal production and sale of cannabis.

 

Investigations result from “proactive strategies and in response to complaints received from the public, government agencies, police, legal market operators and others,” the ministry said in a statement.

 

“All along, the aim has been voluntary compliance, and we have been very clear that once legal cannabis retail outlets became operational in a community, the illegal retailers would face enforcement activities from the CSU.”

 

Smith said the organisation is different from marijuana retailers because it provides a higher level of advice and offers locally sourced products. The Club has been fined $6.5 million for selling marijuana illegally at its previous location on Johnson Street, and the fine is currently under appeal. The organisation is Canada's oldest "compassion club" and has been selling cannabis products openly since 1996.

 

In January 2020, Victoria council passed a motion supporting the club’s request for an exemption from the province’s cannabis regulations, which came as the club was advocating for changes to the rules regarding the production and sale of medical marijuana.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Podcasts and most audio platforms available.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research , guest posts and original  articles and podcasts in leading stock sectors.  Learn about investing in stocks and get  investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.     

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Wednesday, March 15, 2023

Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis, CBD and Psychedelics Industry March 6th, 2023 - March 10th, 2023

Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis, CBD and Psychedelics Industry March 6th, 2023 - March 10th, 2023

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move: #CzechRepublic, US Rescheduling and Raphael Mechoulam

 



 

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move: #CzechRepublic, US Rescheduling and Raphael Mechoulam

 

Delta, Kelowna, BC, March 15, 2023 (Investorideas.com Newswire), investorideas.com,  a global news source covering leading sectors including marijuana and hemp stocks and its potcast site  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

 

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2023/031523-Cannabis.mp3

 

Read this in full at https://www.investorideas.com/news/2023/cannabis-potcasts/03151Czech-Republic.asp

 

Hear Investor ideas cannabis potcast on iTunes  

 

Hear the investor ideas potcast on Spotify

 

Today’s podcast overview/transcript:

 

In today’s podcast we discuss some recent news in Europe regarding the Czech Republic, the progress of cannabis rescheduling in the US, and the death of renowned cannabis researcher Raphael Mechoulam.

 

In recent news out of Europe, Journalist Robert Veverka, director of the Czech-based cannabis magazine Legalizace, was convicted this week of ‘inciting the abuse of addictive substances’ and ‘spreading drug addiction through his magazine’.

 

According to the court in Ostrava, the third largest Czech city, the magazine offered instructions on how to illegally obtain cannabis, how to grow, process and use the plant. From time to time there were also seeds inserted in the magazine, since the sale and possession of cannabis seeds is completely legal in the Czech Republic, and there were disclaimers attached. The court also didn’t like advertisements of fertiliser companies and seed banks, although all the goods are normally sold in gardening shops and are all perfectly legal.

 

Veverka described the “spreading toxicomania” (or the ‘promotion of drug addiction’) section cited in the law as very flexible, sufficiently vague that it can be interpreted in many different ways so that it suits the prosecution, saying:

 

“It is a Bolshevik relic and a relic of totalitarianism. It allows for a loose interpretation of what constitutes incitement to substance abuse.”

 

He points out that it applies to all drugs but one – alcohol. The Czech media are full of adverts glamorising alcohol consumption, and promoting it even to kids. “But if you tell somebody they may want to try cannabis ointment on their knee, you can end up in court,” said the publisher.

 

The decision is definitive, his only remaining option being to appeal to the Supreme and Constitutional Court, which Robert Veverka intends to do– although nobody knows when (and if) these courts would take up the case, because they are overwhelmed.

 

“I will try to take this further to the highest courts to protect not only myself but any other media outlet that chooses to write about cannabis,” he said.

 

Throughout the court case, Mr. Veverka has had the support of prominent politicians from the Czech Pirate Party, of which he is a member.

 

For example, minister of regional development and vice prime minister Ivan BartoÅ¡ wrote on his Facebook: “The Pirate Party will always protect free access to information. In my opinion, in the case of Robert Veverka, the courts are criminalising the sharing of information that is completely harmless to society.”

 

In what has been described as an ‘attack on freedom of information and expression’, the Czech courts appear to be in contradiction with the country’s recent progressive approach to cannabis.

 

Just a month ago, government officials announced the country’s intention to legalise the adult-use of cannabis.

 

Veverka had previously appealed a conviction and sentence handed to him during an initial trial in November 2021.

 

After more than a year of arm wrestling with justice, he was again convicted by the Regional Court of Ostrava on Thursday, 2 March for ‘spreading drug addiction through his magazine’.

 

The news was announced yesterday by his friend and business partner Lukas Hurt in a post on LinkedIn.

 

In other recent news, last week more than a dozen bipartisan congressional lawmakers sent a letter to top Biden administration officials, demanding transparency in the ongoing marijuana scheduling review that the president directed last year.

 

Rep. Earl Blumenauer (D-OR) recently circulated a draft of the letter among colleagues, seeking signatories before sending the final version to U.S. Attorney General Merrick Garland and Health and Human Services (HHS) Secretary Xavier Becerra.

 

The letter states that Biden’s scheduling directive represents “an opportunity to make an honest assessment of the origins and implications of federal policy,” adding that “marijuana was scheduled based on stigma not science,” and it’s “time to address marijuana’s existing reality as a state-regulated substance.”

 

“The administrative review of marijuana’s scheduling should place the burden of evidence on maintaining marijuana’s status as a scheduled substance. To correct the failed war on drugs and cannabis prohibition, the assumption must be that, unless evidence undeniably indicates that marijuana is more prone to drug abuse than unscheduled substances already regulated at the state level, marijuana should be fully descheduled from the Controlled Substances Act.”

 

The lawmakers added that administrative descheduling would “not negate Congress’ obligation to act on comprehensive federal cannabis reform,” and that there are a variety of thoughtful legislative reform proposals that have been introduced in past sessions.

 

“Each of these proposals works to respect the leadership states have demonstrated for 50 years in rethinking the failed and discriminatory war on drugs approach to marijuana,” the letter says. “Given the scope of the federal government’s failure on marijuana, the Administration must also take meaningful action to deschedule marijuana and partner with Congress and the states in the work ahead.”

 

“To ensure accountability in your conclusions—which has been absent in so much of the history of federal marijuana regulation—transparency is key. We urge you to make available for public review and comment any evidence cited to demonstrate marijuana is more prone to drug abuse than descheduled substances already regulated at the state level. With the severe federal restrictions on cannabis research due to marijuana’s scheduling, it’s important that your departments review the full scope of research available. It is time to set the federal government on a better path for marijuana policy and engage transparently with the evidence.”

 

Lastly, Raphael Mechoulam, a renowned Israeli scientist often referred to as the "father of cannabis research," has passed away  at the age of 92.

 

Mechoulam and his team of researchers at Hebrew University began conducting experiments on cannabinoids in the 1960s and were the first to isolate delta-9 THC, the psychoactive component of cannabis. He also designed and synthesised several new cannabinoids with potential as pharmaceutical drugs.

 

Mechoulam was nominated for over 25 academic awards, including the Heinrich Wieland Prize in 2004, an honorary doctorate from Complutense University in Madrid in 2006, and the Israel Prize in Exact Sciences, Chemistry, in 2000. He was a founding member of the International Association for Cannabinoid Medicines and the International Cannabinoid Research Society.

Mechoulam was born in Bulgaria in 1930 and immigrated with his family to Israel in 1949, where he studied chemistry. He later received a Ph.D. from the Weizmann Institute in 1958, focusing on the chemistry of steroids. Mechoulam became a full professor at the Hebrew University of Jerusalem in 1972 after working as a member of the scientific staff of the Weizmann Institute from 1960 to 1965, where he focused on the isolation, structure elucidation, and synthesis of the main active principles of cannabis. His contributions to the scientific community have been immeasurable, and his groundbreaking studies have paved the way for future research on cannabis.

 

“I have spent most of my life decoding the mysteries to be found within this incredible plant,” he said. “I would like to see my colleagues forge ahead with their investigations, advancing even further the acceptance and integration of cannabinoids in traditional medicine.”

 

“Most of the human and scientific knowledge about cannabis was accumulated thanks to Prof. Mechoulam,” Hebrew University President Asher Cohen said in a statement. “He paved the way for groundbreaking studies and initiated scientific cooperation between researchers around the world. Mechoulam was a sharp-minded and charismatic pioneer.”

 

In 2022, the YIVO Institute for Jewish Research in New York City mounted its exhibition on Jewish contributions to the history of cannabis and highlighted the work of Mechoulam. “He’s worked on cannabis his entire life, and in the 1990s he and his colleagues discovered the endocannabinoid system, which regulates homeostasis — a significant discovery on how the human body deals with cannabinoids,” Eddy Portnoy, who curated the exhibit, told the Jewish Telegraphic Agency at the time. “I read an interview with him where he says that because he was in a small country, he would have to find a niche that other people weren’t working in.”

 

Prof. Mechoulam leaves behind his wife Dalia, son Roy and daughters Dafna and Hadas. His funeral was held on Sunday, March 12, in Jerusalem.

 

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

 

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/

 

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio ,  Google Podcasts and most audio platforms available.

 

About Investorideas.com - Big Investing Ideas

We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders.  Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast ,  Cleantech and Climate Change Podcast,  Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast.  We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.